BACKGROUND: Declining function in dopamine circuits is implicated in normal aging and late-life depression (LLD). Dopamine augmentation recently has shown therapeutic promise, but predictors of response are unknown. METHODS: Depressed elders with slowed gait underwent baseline magnetic resonance imaging (MRI) and [11C]raclopride positron emission tomography (PET). Subjects then received open treatment with carbidopa/levodopa (L-DOPA) for three weeks. Linear regressions examined relationships between baseline MRI measures, [11C]raclopride binding, and behavioral outcomes. RESULTS: Among N = 16 participants aged 72.5 ± 6.8 years, higher left superior temporal gyrus volume was associated with higher processing speed at baseline, while cortical thinning in a processing speed network was associated with greater improvement following L-DOPA. Greater volume and cortical thickness in brain regions associated with mobility were associated with higher baseline gait speed. Higher baseline white matter hyperintensity volume predicted less post-L-DOPA improvement on dual task gait speed and IDS-SR scores. Higher [11C]raclopride binding in the associative striatum was associated with cortical thickness in some, but not all, processing speed brain regions, while higher binding in sensorimotor striatum was significantly associated with left caudate volume. LIMITATIONS: Limiting the conclusions drawn from this pilot study are the small sample size and open administration of L-DOPA. CONCLUSIONS: Greater baseline brain volumes and cortical thickness in regions supporting cognition and gait were associated with higher behavioral performance, while lower structural integrity was associated with increased responsivity to L-DOPA. If substantiated in larger studies, these findings could facilitate the targeting of dopaminergic treatments to those LLD patients most likely to respond.
BACKGROUND: Declining function in dopamine circuits is implicated in normal aging and late-life depression (LLD). Dopamine augmentation recently has shown therapeutic promise, but predictors of response are unknown. METHODS:Depressed elders with slowed gait underwent baseline magnetic resonance imaging (MRI) and [11C]raclopride positron emission tomography (PET). Subjects then received open treatment with carbidopa/levodopa (L-DOPA) for three weeks. Linear regressions examined relationships between baseline MRI measures, [11C]raclopride binding, and behavioral outcomes. RESULTS: Among N = 16 participants aged 72.5 ± 6.8 years, higher left superior temporal gyrus volume was associated with higher processing speed at baseline, while cortical thinning in a processing speed network was associated with greater improvement following L-DOPA. Greater volume and cortical thickness in brain regions associated with mobility were associated with higher baseline gait speed. Higher baseline white matter hyperintensity volume predicted less post-L-DOPA improvement on dual task gait speed and IDS-SR scores. Higher [11C]raclopride binding in the associative striatum was associated with cortical thickness in some, but not all, processing speed brain regions, while higher binding in sensorimotor striatum was significantly associated with left caudate volume. LIMITATIONS: Limiting the conclusions drawn from this pilot study are the small sample size and open administration of L-DOPA. CONCLUSIONS: Greater baseline brain volumes and cortical thickness in regions supporting cognition and gait were associated with higher behavioral performance, while lower structural integrity was associated with increased responsivity to L-DOPA. If substantiated in larger studies, these findings could facilitate the targeting of dopaminergic treatments to those LLDpatients most likely to respond.
Authors: Monique A Pimontel; Michelle E Culang-Reinlieb; Sarah S Morimoto; Joel R Sneed Journal: Int J Geriatr Psychiatry Date: 2011-10-18 Impact factor: 3.485
Authors: Joel R Sneed; Bret R Rutherford; David Rindskopf; David T Lane; Harold A Sackeim; Steven P Roose Journal: Am J Geriatr Psychiatry Date: 2007-11-12 Impact factor: 4.105
Authors: Rahul S Desikan; Florent Ségonne; Bruce Fischl; Brian T Quinn; Bradford C Dickerson; Deborah Blacker; Randy L Buckner; Anders M Dale; R Paul Maguire; Bradley T Hyman; Marilyn S Albert; Ronald J Killiany Journal: Neuroimage Date: 2006-03-10 Impact factor: 6.556
Authors: Patrick J Brown; Steven P Roose; Jun Zhang; Melanie Wall; Bret R Rutherford; Hilsa N Ayonayon; Meryl A Butters; Tamara Harris; Anne B Newman; Suzanne Satterfield; Eleanor M Simonsick; Kristine Yaffe Journal: J Gerontol A Biol Sci Med Sci Date: 2015-09-20 Impact factor: 6.053
Authors: Yvette I Sheline; Brianne M Disabato; Jennifer Hranilovich; Carrie Morris; Gina D'Angelo; Carl Pieper; Tommaso Toffanin; Warren D Taylor; James R MacFall; Consuelo Wilkins; Deanna M Barch; Kathleen A Welsh-Bohmer; David C Steffens; Ranga R Krishnan; P Murali Doraiswamy Journal: Am J Psychiatry Date: 2012-11 Impact factor: 18.112
Authors: Panayotes Demakakos; Rachel Cooper; Mark Hamer; Cesar de Oliveira; Rebecca Hardy; Elizabeth Breeze Journal: PLoS One Date: 2013-07-09 Impact factor: 3.240
Authors: Simon Moskowitz; David W Russ; Leatha A Clark; Nathan P Wages; Dustin R Grooms; Adam J Woods; Julie Suhr; Janet E Simon; Andrew O'Shea; Cody R Criss; Paolo Fadda; Brian C Clark Journal: Geroscience Date: 2020-11-24 Impact factor: 7.713